Loading clinical trials...

Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC) | Clinical Trials | Clareo Health

Active Not RecruitingNANCT05092516

Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)

The main goal of this study is to improve dysexecutive symptoms (e.g., sustained attention, processing speed) in patients exhibiting post-acute sequelae of COVID-19 (PASC) through home-based transcran...

Lead sponsor: Massachusetts General Hospital•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment40

Start dateJun 2022

Last updatedNov 10, 2025

Condition

Dysexecutive Syndrome Post-Acute Sequelae of COVID-19

Locations shown

Massachusetts General Hospital

Charlestown, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 10, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions